Pacific Center for Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.5K | Hold |
350
| – | – | 0.01% | 241 |
|
2025
Q1 | $25.7K | Hold |
350
| – | – | 0.01% | 235 |
|
2024
Q4 | $22.9K | Hold |
350
| – | – | 0.01% | 248 |
|
2024
Q3 | $27.3K | Hold |
350
| – | – | 0.01% | 230 |
|
2024
Q2 | $27.3K | Hold |
350
| – | – | 0.01% | 223 |
|
2024
Q1 | $23.7K | Hold |
350
| – | – | 0.01% | 233 |
|
2023
Q4 | $23.6K | Hold |
350
| – | – | 0.01% | 221 |
|
2023
Q3 | $23.7K | Hold |
350
| – | – | 0.01% | 221 |
|
2023
Q2 | $25.1K | Hold |
350
| – | – | 0.01% | 208 |
|
2023
Q1 | $24.3K | Buy |
+350
| New | +$24.3K | 0.01% | 210 |
|
2022
Q3 | $19K | Hold |
350
| – | – | 0.01% | 229 |
|
2022
Q2 | $23K | Hold |
350
| – | – | 0.01% | 206 |
|
2022
Q1 | $23K | Hold |
350
| – | – | 0.01% | 221 |
|
2021
Q4 | $20K | Hold |
350
| – | – | 0.01% | 234 |
|
2021
Q3 | $21K | Hold |
350
| – | – | 0.01% | 225 |
|
2021
Q2 | $21K | Hold |
350
| – | – | 0.01% | 217 |
|
2021
Q1 | $17K | Hold |
350
| – | – | 0.01% | 224 |
|
2020
Q4 | $17K | Hold |
350
| – | – | 0.01% | 217 |
|
2020
Q3 | $19K | Hold |
350
| – | – | 0.01% | 179 |
|
2020
Q2 | $19K | Hold |
350
| – | – | 0.01% | 172 |
|
2020
Q1 | $16K | Hold |
350
| – | – | 0.01% | 164 |
|
2019
Q4 | $17K | Hold |
350
| – | – | 0.01% | 181 |
|
2019
Q3 | $16K | Hold |
350
| – | – | 0.01% | 186 |
|
2019
Q2 | $14K | Hold |
350
| – | – | 0.01% | 191 |
|
2019
Q1 | $14K | Hold |
350
| – | – | 0.01% | 186 |
|
2018
Q4 | $13K | Hold |
350
| – | – | 0.01% | 194 |
|
2018
Q3 | $14K | Hold |
350
| – | – | 0.01% | 192 |
|
2018
Q2 | $12K | Hold |
350
| – | – | 0.01% | 190 |
|
2018
Q1 | $12K | Hold |
350
| – | – | 0.01% | 187 |
|
2017
Q4 | $12K | Hold |
350
| – | – | 0.01% | 185 |
|
2017
Q3 | $12K | Hold |
350
| – | – | 0.01% | 181 |
|
2017
Q2 | $12K | Hold |
350
| – | – | 0.01% | 175 |
|
2017
Q1 | $11K | Hold |
350
| – | – | 0.01% | 175 |
|
2016
Q4 | $10K | Buy |
+350
| New | +$10K | 0.01% | 184 |
|